About Xell
Xell is a Healthcare company based in Bielefeld (Germany) founded in 2009, and was acquired by Sartorius in July 2021. Specialized media and feeds for cell culture are provided. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Diversified. Its legal entity is Sartorius Xell GmbH.
Company details
Xell was founded in 2009 and is headquartered in Bielefeld, Germany. Operations focus on the biotech and pharmaceutical sectors, where media and feed solutions for CHO, HEK, and hybridoma cells are manufactured. Services include development and optimization of culture media using metabolic models and analytical tools, along with process development, lot testing, raw material evaluation, and supplier assessments. Analytical services are also extended to clients.
Investors in Xell
Xell has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Sartorius.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Laboratory and biopharmaceutical equipment is developed for production processes. | 1870 | sartorius.com | Gottingen, Germany |
Investor details for Xell
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Xell
2 dated milestones of Xell across 12 years, from founding to its latest funding, stage changes and deals.
- Founded Xell is founded.
- Exit Acquired by Sartorius.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Xell
Complete news archive for Xell
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Xell
Xell was founded in 2009.
Xell is headquartered in Bielefeld, Germany. It is registered at Bielefeld, North Rhine-westphalia, Germany.
Xell was founded in 2009 and is headquartered in Bielefeld, Germany. Operations focus on the biotech and pharmaceutical sectors, where media and feed solutions for CHO, HEK, and hybridoma cells are manufactured. Services include development and optimization of culture media using metabolic models and analytical tools, along with process development, lot testing, raw material evaluation, and supplier assessments. Analytical services are also extended to clients.
Xell has 1 investor. Key investors include Sartorius.
Xell operates through Sartorius Xell Gmbh.
Yes. Xell was acquired by Sartorius in July 2021.